First Header Logo Second Header Logo

Connection

Ralph D'Agostino to Insulin Resistance

Back to Details
This is a "connection" page, showing publications Ralph D'Agostino has written about Insulin Resistance.
Ralph D'Agostino
Connection Strength
2.497
Insulin Resistance
  1. D'Agostino RB, Hamman RF, Karter AJ, Mykkanen L, Wagenknecht LE, Haffner SM. Cardiovascular disease risk factors predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes Care. 2004 Sep; 27(9):2234-40.
    View in: PubMed
    Score: 0.194
  2. Howard G, Bergman R, Wagenknecht LE, Haffner SM, Savage PJ, Saad MF, Laws A, D'Agostino RB. Ability of alternative indices of insulin sensitivity to predict cardiovascular risk: comparison with the "minimal model". Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Ann Epidemiol. 1998 Aug; 8(6):358-69.
    View in: PubMed
    Score: 0.127
  3. Melton CD, Luo R, Wong BJ, Spasojevic I, Wagenknecht LE, D'Agostino RB, Il'yasova D. Urinary F2-isoprostanes and the risk of hypertension. Ann Epidemiol. 2017 06; 27(6):391-396.
    View in: PubMed
    Score: 0.117
  4. D'Agostino RB, Burke G, O'Leary D, Rewers M, Selby J, Savage PJ, Saad MF, Bergman RN, Howard G, Wagenknecht L, Haffner SM. Ethnic differences in carotid wall thickness. The Insulin Resistance Atherosclerosis Study. Stroke. 1996 Oct; 27(10):1744-9.
    View in: PubMed
    Score: 0.112
  5. Shah AS, Black S, Wadwa RP, Schmiege SJ, Fino NF, Talton JW, D'Agostino R, Hamman RF, Urbina EM, Dolan LM, Daniels SR, Marcovina SM, Dabelea D. Insulin sensitivity and arterial stiffness in youth with type 1 diabetes: the SEARCH CVD study. J Diabetes Complications. 2015 May-Jun; 29(4):512-6.
    View in: PubMed
    Score: 0.100
  6. Mottl AK, Lauer A, Dabelea D, Maahs DM, D'Agostino RB, Dolan LM, Gilliam LK, Lawrence JM, Rodriguez B, Marcovina SM, Imperatore G, Kanakatti Shankar R, Afkarian M, Reynolds K, Liese AD, Mauer M, Mayer-Davis EJ. Albuminuria according to status of autoimmunity and insulin sensitivity among youth with type 1 and type 2 diabetes. Diabetes Care. 2013 Nov; 36(11):3633-8.
    View in: PubMed
    Score: 0.090
  7. Dabelea D, Mayer-Davis EJ, Andrews JS, Dolan LM, Pihoker C, Hamman RF, Greenbaum C, Marcovina S, Fujimoto W, Linder B, Imperatore G, D'Agostino R. Clinical evolution of beta cell function in youth with diabetes: the SEARCH for Diabetes in Youth study. Diabetologia. 2012 Dec; 55(12):3359-68.
    View in: PubMed
    Score: 0.085
  8. Sedjo RL, D'Agostino RB, Ahnen D, Levin TR, Haffner SM, Tooze JA, Byers T. Lack of association between insulin sensitivity and colorectal adenoma risk. Nutr Cancer. 2011; 63(1):6-11.
    View in: PubMed
    Score: 0.075
  9. Lorenzo C, Wagenknecht LE, D'Agostino RB, Rewers MJ, Karter AJ, Haffner SM. Insulin resistance, beta-cell dysfunction, and conversion to type 2 diabetes in a multiethnic population: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 2010 Jan; 33(1):67-72.
    View in: PubMed
    Score: 0.069
  10. MacKay MF, Haffner SM, Wagenknecht LE, D'Agostino RB, Hanley AJ. Prediction of type 2 diabetes using alternate anthropometric measures in a multi-ethnic cohort: the insulin resistance atherosclerosis study. Diabetes Care. 2009 May; 32(5):956-8.
    View in: PubMed
    Score: 0.066
  11. Hanley AJ, Wagenknecht LE, Festa A, D'Agostino RB, Haffner SM. Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 2007 Jul; 30(7):1819-27.
    View in: PubMed
    Score: 0.058
  12. Festa A, Williams K, D'Agostino R, Wagenknecht LE, Haffner SM. The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. Diabetes. 2006 Apr; 55(4):1114-20.
    View in: PubMed
    Score: 0.054
  13. Liese AD, Schulz M, Fang F, Wolever TM, D'Agostino RB, Sparks KC, Mayer-Davis EJ. Dietary glycemic index and glycemic load, carbohydrate and fiber intake, and measures of insulin sensitivity, secretion, and adiposity in the Insulin Resistance Atherosclerosis Study. Diabetes Care. 2005 Dec; 28(12):2832-8.
    View in: PubMed
    Score: 0.053
  14. Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB, Haffner SM. Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes. 2005 Nov; 54(11):3140-7.
    View in: PubMed
    Score: 0.053
  15. Karter AJ, D'Agostino RB, Mayer-Davis EJ, Wagenknecht LE, Hanley AJ, Hamman RF, Bergman R, Saad MF, Haffner SM. Abdominal obesity predicts declining insulin sensitivity in non-obese normoglycaemics: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Obes Metab. 2005 May; 7(3):230-8.
    View in: PubMed
    Score: 0.051
  16. Goff DC, D'Agostino RB, Haffner SM, Otvos JD. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study. Metabolism. 2005 Feb; 54(2):264-70.
    View in: PubMed
    Score: 0.050
  17. Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB, Kempf J, Zinman B, Haffner SM. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes. 2004 Oct; 53(10):2623-32.
    View in: PubMed
    Score: 0.049
  18. Hanley AJ, Festa A, D'Agostino RB, Wagenknecht LE, Savage PJ, Tracy RP, Saad MF, Haffner SM. Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity. Diabetes. 2004 Jul; 53(7):1773-81.
    View in: PubMed
    Score: 0.048
  19. Festa A, D'Agostino R, Hanley AJ, Karter AJ, Saad MF, Haffner SM. Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes. 2004 Jun; 53(6):1549-55.
    View in: PubMed
    Score: 0.048
  20. Hanley AJ, Wagenknecht LE, D'Agostino RB, Zinman B, Haffner SM. Identification of subjects with insulin resistance and beta-cell dysfunction using alternative definitions of the metabolic syndrome. Diabetes. 2003 Nov; 52(11):2740-7.
    View in: PubMed
    Score: 0.046
  21. Williams K, Sniderman AD, Sattar N, D'Agostino R, Wagenknecht LE, Haffner SM. Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2003 Nov 11; 108(19):2312-6.
    View in: PubMed
    Score: 0.046
  22. Haffner SM, D'Agostino R, Festa A, Bergman RN, Mykkänen L, Karter A, Saad MF, Wagenknecht LE. Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors? Diabetes Care. 2003 Oct; 26(10):2796-803.
    View in: PubMed
    Score: 0.046
  23. Festa A, Hanley AJ, Tracy RP, D'Agostino R, Haffner SM. Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion. Circulation. 2003 Oct 14; 108(15):1822-30.
    View in: PubMed
    Score: 0.046
  24. Festa A, D'Agostino R, Rich SS, Jenny NS, Tracy RP, Haffner SM. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Circulation. 2003 May 20; 107(19):2422-7.
    View in: PubMed
    Score: 0.044
  25. Hanley AJ, Williams K, Gonzalez C, D'Agostino RB, Wagenknecht LE, Stern MP, Haffner SM. Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study. Diabetes. 2003 Feb; 52(2):463-9.
    View in: PubMed
    Score: 0.044
  26. Hanley AJ, Karter AJ, Festa A, D'Agostino R, Wagenknecht LE, Savage P, Tracy RP, Saad MF, Haffner S. Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study. Diabetes. 2002 Aug; 51(8):2642-7.
    View in: PubMed
    Score: 0.042
  27. Festa A, D'Agostino R, Tracy RP, Haffner SM. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes. 2002 Apr; 51(4):1131-7.
    View in: PubMed
    Score: 0.041
  28. Festa A, D'Agostino R, Rautaharju P, Mykkänen L, Haffner SM. Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in nondiabetic and type 2 diabetic subjects. Am J Cardiol. 2000 Nov 15; 86(10):1117-22.
    View in: PubMed
    Score: 0.037
  29. Bell RA, Mayer-Davis EJ, Martin MA, D'Agostino RB, Haffner SM. Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study. Diabetes Care. 2000 Nov; 23(11):1630-6.
    View in: PubMed
    Score: 0.037
  30. Festa A, D'Agostino R, Howard G, Mykkänen L, Tracy RP, Haffner SM. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int. 2000 Oct; 58(4):1703-10.
    View in: PubMed
    Score: 0.037
  31. Festa A, D'Agostino R, Howard G, Mykkänen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000 Jul 04; 102(1):42-7.
    View in: PubMed
    Score: 0.036
  32. Festa A, D'Agostino R, Hales CN, Mykkänen L, Haffner SM. Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects. Diabetes Care. 2000 May; 23(5):624-8.
    View in: PubMed
    Score: 0.036
  33. Festa A, D'Agostino R, Mykkänen L, Tracy RP, Hales CN, Howard BV, Haffner SM. LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study. Diabetes Care. 1999 Oct; 22(10):1688-93.
    View in: PubMed
    Score: 0.035
  34. Festa A, D'Agostino R, Rautaharju P, O'Leary DH, Rewers M, Mykkänen L, Haffner SM. Is QT interval a marker of subclinical atherosclerosis in nondiabetic subjects? The Insulin Resistance Atherosclerosis Study (IRAS). Stroke. 1999 Aug; 30(8):1566-71.
    View in: PubMed
    Score: 0.034
  35. Urbina EM, Isom S, Bell RA, Bowlby DA, D'Agostino R, Daniels SR, Dolan LM, Imperatore G, Marcovina SM, Merchant AT, Reynolds K, Shah AS, Wadwa RP, Dabelea D. Burden of Cardiovascular Risk Factors Over Time and Arterial Stiffness in Youth With Type 1 Diabetes Mellitus: The SEARCH for Diabetes in Youth Study. J Am Heart Assoc. 2019 07 02; 8(13):e010150.
    View in: PubMed
    Score: 0.034
  36. Haffner SM, D'Agostino R, Mykkänen L, Tracy R, Howard B, Rewers M, Selby J, Savage PJ, Saad MF. Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 1999 Apr; 22(4):562-8.
    View in: PubMed
    Score: 0.033
  37. Festa A, D'Agostino R, Mykkänen L, Tracy RP, Zaccaro DJ, Hales CN, Haffner SM. Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS). Arterioscler Thromb Vasc Biol. 1999 Mar; 19(3):562-8.
    View in: PubMed
    Score: 0.033
  38. Festa A, D'Agostino R, Mykkänen L, Tracy R, Howard BV, Haffner SM. Low-density lipoprotein particle size is inversely related to plasminogen activator inhibitor-1 levels. The Insulin Resistance Atherosclerosis Study. Arterioscler Thromb Vasc Biol. 1999 Mar; 19(3):605-10.
    View in: PubMed
    Score: 0.033
  39. Haffner SM, D'Agostino R, Mykkänen L, Hales CN, Savage PJ, Bergman RN, O'Leary D, Rewers M, Selby J, Tracy R, Saad MF. Proinsulin and insulin concentrations in relation to carotid wall thickness: Insulin Resistance Atherosclerosis Study. Stroke. 1998 Aug; 29(8):1498-503.
    View in: PubMed
    Score: 0.032
  40. Karter AJ, Mayer-Davis EJ, Selby JV, D'Agostino RB, Haffner SM, Sholinsky P, Bergman R, Saad MF, Hamman RF. Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin Resistance and Atherosclerosis Study. Diabetes. 1996 Nov; 45(11):1547-55.
    View in: PubMed
    Score: 0.028
  41. Haffner SM, D'Agostino R, Saad MF, Rewers M, Mykkänen L, Selby J, Howard G, Savage PJ, Hamman RF, Wagenknecht LE, et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes. 1996 Jun; 45(6):742-8.
    View in: PubMed
    Score: 0.027
  42. The NS, Crandell JL, Lawrence JM, King IB, Dabelea D, Marcovina SM, D'Agostino RB, Norris JM, Pihoker C, Mayer-Davis EJ. Vitamin D in youth with Type 1 diabetes: prevalence of insufficiency and association with insulin resistance in the SEARCH Nutrition Ancillary Study. Diabet Med. 2013 Nov; 30(11):1324-32.
    View in: PubMed
    Score: 0.023
  43. Il'yasova D, Wang F, Spasojevic I, Base K, D'Agostino RB, Wagenknecht LE. Racial differences in urinary F2-isoprostane levels and the cross-sectional association with BMI. Obesity (Silver Spring). 2012 Oct; 20(10):2147-50.
    View in: PubMed
    Score: 0.021
  44. Dabelea D, Pihoker C, Talton JW, D'Agostino RB, Fujimoto W, Klingensmith GJ, Lawrence JM, Linder B, Marcovina SM, Mayer-Davis EJ, Imperatore G, Dolan LM. Etiological approach to characterization of diabetes type: the SEARCH for Diabetes in Youth Study. Diabetes Care. 2011 Jul; 34(7):1628-33.
    View in: PubMed
    Score: 0.019
  45. Hanley AJ, Karter AJ, Williams K, Festa A, D'Agostino RB, Wagenknecht LE, Haffner SM. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Circulation. 2005 Dec 13; 112(24):3713-21.
    View in: PubMed
    Score: 0.013
  46. Sattar N, Williams K, Sniderman AD, D'Agostino R, Haffner SM. Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study. Circulation. 2004 Oct 26; 110(17):2687-93.
    View in: PubMed
    Score: 0.012
  47. Festa A, D'Agostino R, Tracy RP, Haffner SM. C-reactive protein is more strongly related to post-glucose load glucose than to fasting glucose in non-diabetic subjects; the Insulin Resistance Atherosclerosis Study. Diabet Med. 2002 Nov; 19(11):939-43.
    View in: PubMed
    Score: 0.011
  48. Hanley AJ, D'Agostino R, Wagenknecht LE, Saad MF, Savage PJ, Bergman R, Haffner SM. Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study. Diabetes. 2002 Apr; 51(4):1263-70.
    View in: PubMed
    Score: 0.010
  49. Festa A, D'Agostino R, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, Haffner SM. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord. 2001 Oct; 25(10):1407-15.
    View in: PubMed
    Score: 0.010
  50. Goff DC, D'Agostino RB, Haffner SM, Saad MF, Wagenknecht LE. Lipoprotein concentrations and carotid atherosclerosis by diabetes status: results from the Insulin Resistance Atherosclerosis Study. Diabetes Care. 2000 Jul; 23(7):1006-11.
    View in: PubMed
    Score: 0.009
  51. Haffner SM, D'Agostino R, Goff D, Howard B, Festa A, Saad MF, Mykkänen L. LDL size in African Americans, Hispanics, and non-Hispanic whites : the insulin resistance atherosclerosis study. Arterioscler Thromb Vasc Biol. 1999 Sep; 19(9):2234-40.
    View in: PubMed
    Score: 0.009
  52. Dubuisson JT, Wagenknecht LE, D'Agostino RB, Haffner SM, Rewers M, Saad MF, Laws A, Herrington DM. Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes. Diabetes Care. 1998 Nov; 21(11):1790-6.
    View in: PubMed
    Score: 0.008
  53. Wagenknecht LE, D'Agostino RB, Haffner SM, Savage PJ, Rewers M. Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 1998 Nov; 21(11):1812-8.
    View in: PubMed
    Score: 0.008
  54. Mayer-Davis EJ, D'Agostino R, Karter AJ, Haffner SM, Rewers MJ, Saad M, Bergman RN. Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study. JAMA. 1998 Mar 04; 279(9):669-74.
    View in: PubMed
    Score: 0.008
  55. Wagenknecht LE, D'Agostino R, Savage PJ, O'Leary DH, Saad MF, Haffner SM. Duration of diabetes and carotid wall thickness. The Insulin Resistance Atherosclerosis Study (IRAS). Stroke. 1997 May; 28(5):999-1005.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.